New Hampshire 2025 Regular Session

New Hampshire House Bill HB705

Introduced
1/22/25  
Refer
1/22/25  
Report Pass
3/19/25  
Engrossed
3/28/25  
Refer
3/28/25  
Refer
4/17/25  

Caption

Relative to health care cost transparency.

Impact

If enacted, HB705 would create a legal framework requiring health carriers to make available specific price-related information in machine-readable formats on their websites. The bill's requirements include disclosing in-network provider rates, out-of-network allowed amounts, billed charges, and negotiated rates for prescription drugs. This aim for increased transparency may lead to a significant shift in how health care costs are communicated to consumers, potentially empowering them to make more informed decisions regarding their health care coverage and treatment options.

Summary

House Bill 705 addresses the issue of health care cost transparency by mandating health carriers to disclose specific cost information regarding covered items and services under health benefit plans. The legislation aims to provide greater clarity to consumers regarding costs associated with health care services and prescription drugs. This initiative is a response from the state's insurance department, focusing on enhancing consumer awareness and fostering better cost comparison, which is increasingly seen as essential in the current healthcare landscape.

Sentiment

The sentiment around HB705 appears to be largely positive among advocates of health care reform and consumer protection, who view it as a step toward fairer and more transparent health care practices. There is a general consensus among supporters that by equipping consumers with necessary financial information, they can better navigate health care choices. However, there may be challenges related to the effective implementation of these transparency measures, particularly concerning the technological capabilities of health carriers to comply with the new requirements.

Contention

Despite its intended benefits, notable points of contention could arise around the feasibility and effectiveness of the disclosure requirements. Critics may argue that simply increasing the availability of information does not guarantee affordability or accessibility of care. Concerns might also focus on the potential burden placed on health carriers in terms of compliance, as well as the risk that consumers may find the information overwhelming or difficult to interpret without proper context. Nevertheless, the overall expectation is that the bill will provide essential groundwork for future legislative efforts addressing transparency in the health care sector.

Companion Bills

No companion bills found.

Similar Bills

CA AB864

Controlled substances: CURES database.

CA AB1753

Controlled substances: CURES database.

CA AB528

Controlled substances: CURES database.

CA SB1240

Prescription drugs: CURES database.

CA SB838

Health care: prescription drugs.

CA AB1751

Controlled substances: CURES database.

CA AB2086

Controlled substances: CURES database.

CA SB641

Mexican prepaid health plans.